Balakin Konstantin V, Ekins Sean, Bugrim Andrey, Ivanenkov Yan A, Korolev Dmitry, Nikolsky Yuri V, Skorenko Andrey V, Ivashchenko Andrey A, Savchuk Nikolay P, Nikolskaya Tatiana
Chemical Diversity Labs, Inc., San Diego, CA, USA.
Drug Metab Dispos. 2004 Oct;32(10):1183-9. doi: 10.1124/dmd.104.000356. Epub 2004 Jul 1.
The drug development process utilizes the parallel assessment of activity at a therapeutic target as well as absorption, distribution, metabolism, excretion, and toxicity properties of molecules. The development of novel, reliable, and inexpensive computational methods for the early assessment of metabolism and toxicity is becoming increasingly an important part of this process. We have used a computational approach for the assessment of drugs and drug-like compounds which bind to the cytochromes P450 (P450s) with experimentally determined Km values. The physicochemical properties of these compounds were calculated using molecular descriptor software and then analyzed using Kohonen self-organizing maps. This approach was applied to generate a P450-specific classification of nearly 500 drug compounds. We observed statistically significant differences in the molecular properties of low Km molecules for various P450s and suggest a relationship between 33 of these compounds and their CYP3A4-inhibitory activity. A test set of additional CYP3A4 inhibitors was used, and 13 of 15 of these molecules were colocated in the regions of low Km values. This computational approach represents a novel method for use in the generation of metabolism models, enabling the scoring of libraries of compounds for their Km values to numerous P450s.
药物研发过程利用了对治疗靶点活性以及分子的吸收、分布、代谢、排泄和毒性特性的并行评估。开发新颖、可靠且廉价的用于早期评估代谢和毒性的计算方法正日益成为这一过程的重要组成部分。我们采用了一种计算方法来评估与细胞色素P450(P450s)结合且具有实验测定Km值的药物和类药物化合物。使用分子描述符软件计算这些化合物的物理化学性质,然后使用Kohonen自组织映射进行分析。该方法被用于生成近500种药物化合物的P450特异性分类。我们观察到不同P450的低Km分子在分子性质上存在统计学显著差异,并表明其中33种化合物与其CYP3A4抑制活性之间存在关联。使用了一组额外的CYP3A4抑制剂测试集,其中15种分子中的13种位于低Km值区域。这种计算方法代表了一种用于生成代谢模型的新方法,能够对众多P450的化合物库进行Km值评分。